The value of the blood glucose test strip market increased in 2015 and
modest growth is expected to continue over the forecast period, driven
by increasing unit sales and limited by ASP erosion. Unit sales growth
will be driven by the increasing patient population and, as a result,
increasing number of diabetics that are testing their blood glucose
levels. Pricing pressure in the competitive landscape and on national
healthcare budgets is expected to result in persistent ASP declines in
test strips during the forecast period.